Advancing Transcatheter Aortic Valve Replacement to the Frontiers of Lifetime Valve Management: Deliberations From the OBSERVANT II Trial

Circ Cardiovasc Interv. 2022 Dec;15(12):e012607. doi: 10.1161/CIRCINTERVENTIONS.122.012607. Epub 2022 Dec 9.

Authors

Andrew Tully^{1

2}, Stephanie Tom^{2

3}, Charles Crepy D'Orleans⁴, Kendra J Grubb^{1

2}

Affiliations

¹ Division of Cardiothoracic Surgery, Emory University, Atlanta, GA (A.T., K.J.G.).
² Structural Heart and Valve Center, Emory University, Atlanta, GA (A.T., S.T., K.J.G.).
³ Department of Surgery, Emory University, Atlanta, GA (S.T.).
⁴ Emory University School of Medicine, Atlanta, GA (C.C.D.).

PMID: 36484238
DOI: 10.1161/CIRCINTERVENTIONS.122.012607

No abstract available

Keywords: Editorials; lifetime valve management; transcatheter aortic valve implantation; transcatheter aortic valve replacement.

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / surgery
Aortic Valve Stenosis* / diagnostic imaging
Aortic Valve Stenosis* / surgery
Heart Valve Prosthesis Implantation* / adverse effects
Heart Valve Prosthesis*
Humans
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome